Stock Information
Myriad Genetics Inc (MYGN)
Ticker Symbol: MYGN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $442.77 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -3.9529
Revenue (TTM): $8.82 M
Dividend Yield: N/A%
ROE: -79.81%
Latest News
-
Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine
Fri, May 8, 2026 1:25 PM
-
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
Thu, May 7, 2026 4:06 PM
-
TD Cowen Maintains Hold on Myriad Genetics, Lowers Price Target to $6
Wed, May 6, 2026 3:39 PM
-
Wells Fargo Maintains Equal-Weight on Myriad Genetics, Lowers Price Target to $5.5
Wed, May 6, 2026 9:40 AM
-
Myriad Genetics (NASDAQ:MYGN) Plunges 14% After Q1 Earnings Beat Revenue Estimates But Miss EPS
Tue, May 5, 2026 11:38 PM
-
Myriad Genetics, Inc. (MYGN) Q1 2026 Earnings Call Transcript
Tue, May 5, 2026 11:31 PM
-
Transcript : Myriad Genetics, Inc., Q1 2026 Earnings Call, May 05, 2026
Tue, May 5, 2026 11:20 PM
-
Myriad: Q1 Earnings Snapshot
Tue, May 5, 2026 5:15 PM
-
Myriad Genetics Affirms FY2026 Sales Guidance of $860.000M-$880.000M vs $864.099M Est
Tue, May 5, 2026 4:06 PM
-
Myriad Genetics Q1 Adj. EPS $(0.09) Misses $(0.07) Estimate, Sales $200.400M Miss $202.484M Estimate
Tue, May 5, 2026 4:06 PM
Key Financials
Financial data not available
